What Changed
Full IR Briefing →Company Overview
Leadership Team
Chief Financial Officer
Executive Chairman · Since May 1, 2014
Chief Financial Officer · Since Jan 1, 2011
Chief People Officer · Since Sep 1, 2023
Chief Executive Officer · Since Sep 1, 2023
President of Injectables · Since Sep 1, 2023
Executive Vice President, Strategic Planning and Global Affairs · Since Jan 1, 2012
Executive Vice Chairman, President of MENA · Since Sep 8, 2005
Executive Vice President, Corporate Development and M&A · Since Jan 1, 2014
Senior Vice President, Corporate Quality Compliance/Health and Safety · Since Feb 1, 2024
President of Generics · Since Apr 1, 2024
Recent Announcements
No announcements yet.
Data Sources
See Data Freshness Monitor for platform-wide data quality.
Price Chart
Key Metrics
Governance Score
Strong
8-factor live score
Dividend Safety
0/100
Accounting Quality
55/100
Caution: M-Score elevated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Frequently Asked Questions about Hikma Pharmaceuticals PLC
Where is Hikma Pharmaceuticals PLC listed?
Hikma Pharmaceuticals PLC is listed on the Amman Stock Exchange (ASE) in Jordan under the ticker HITS. SouqData profiles its financials, board and shareholders from public exchange disclosures.
What sector is Hikma Pharmaceuticals PLC in?
Hikma Pharmaceuticals PLC (ASE: HITS) is classified in the Health Care sector. This classification is what SouqData uses for its sector rankings and peer comparisons.
How many directors are on the Hikma Pharmaceuticals PLC board?
Hikma Pharmaceuticals PLC has 8 current board members on record at SouqData, 5 of whom are classed as independent, according to the latest board data drawn from public disclosures.
Who is the chairman of Hikma Pharmaceuticals PLC?
Samih Darwazah is the chair of the Hikma Pharmaceuticals PLC (ASE: HITS) board, according to the latest board data held by SouqData from public exchange disclosures.
Hikma Pharmaceuticals PLC vs sector peers
Health Care · unknown-cap · 5 peers shown| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Hikma Pharmaceuticals PLC (HITS) | — | — | 42(D) | — |
| Dar Al Dawa Development and Investment (DARAT · ASE) | $14M | — | — | — |
| Middle East Pharmaceutical & Chemical Industries (MPHA · ASE) | — | — | — | — |
| Arab Center for Pharmaceutical & Chemical Industries (APHC · ASE) | — | — | — | — |
| International Holding Company PJSC (IHC · ADX) | $232.9B | — | 42(D) | — |
| Dr. Sulaiman Al-Habib Medical Services Group Co. (4013 · TDWL) | $6.3B | 1.91% | 42(D) | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 58 sector peers.
Unlock the full SouqData platform
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.